Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
William A. Wexler Insider Profile
4 Followers
William A. Wexler, Director at Eterna Therapeutics, holds ― shares in Eterna Therapeutics (Ticker: ERNA), holds 20.81K shares in Comera Life Sciences Holdings (Ticker: CMRA). Most recently, William A. Wexler ― shares of Eterna Therapeutics on ― for an estimated value of ―.
William A. Wexler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that William A. Wexler holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by William A. Wexler
William A. Wexler's Trading History
Eterna Therapeutics
―
Director
―
―
Comera Life Sciences Holdings
Nov 17, 2023
Director
Uninformative Buy
―
$624.33
List of latest transactions for each holding click on a transaction to see William A. Wexler's performance on stock
You May Also Like
William A. Wexler insider profile FAQ
What is the percentage of profitable transactions made by William A. Wexler?
The percentage of profitable transactions made by William A. Wexler is ―.
What is the average return per transaction made by William A. Wexler?
The average return per transaction made by William A. Wexler is ―.
What stocks does William A. Wexler hold?
William A. Wexler holds: ERNA, CMRA stocks.
What was William A. Wexler’s latest transaction?
William A. Wexler latest transaction was an Uninformative Buy of ―.
What was William A. Wexler's most profitable transaction?
William A. Wexler’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is William A. Wexler's role in Eterna Therapeutics?
William A. Wexler's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.